Medifast (MED) Tops Q4 EPS by 148c

Medifast (NYSE: MED) reported Q4 EPS of $3.70, $1.48 better than the analyst estimate of $2.22. Revenue for the quarter came in at $337.2 million versus the consensus estimate of $330.1 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley